Alphonse E. Leure-duPree All publications ( 9 ) Zagon IS. Jaglowski JR. Verderame MF. Smith JP. Leure-Dupree AE. McLaughlin PJ. Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma. 2005 Nov. Cancer Chemother Pharmacol. 56(5):510-20. McLaughlin PJ. Jaglowski JR. Verderame MF. Stack BC. Leure-Dupree AE. Zagon IS. Enhanced growth inhibition of squamous cell carcinoma of the head and neck by combination therapy of paclitaxel and opioid growth factor. 2005 Mar. Int J Oncol. 26(3):809-16. Jaglowski JR. Zagon IS. Stack BC. Verderame MF. Leure-duPree AE. Manning JD. McLaughlin PJ. Opioid growth factor enhances tumor growth inhibition and increases the survival of paclitaxel-treated mice with squamous cell carcinoma of the head and neck. 2005 Jul. Cancer Chemother Pharmacol. 56(1):97-104. Zagon IS. Ruth TB. Leure-duPree AE. Sassani JW. McLaughlin PJ. Immunoelectron microscopic localization of the opioid growth factor receptor (OGFr) and OGF in the cornea. 2003 Mar 28. Brain Res. 967(1-2):37-47. National Eye Institute Craven RC. Leure-duPree AE. Weldon RA. Wills JW. Genetic analysis of the major homology region of the Rous sarcoma virus Gag protein. 1995 Jul. J Virol. 69(7):4213-27. National Cancer Institute Kimball SR. Chen SJ. Risica R. Jefferson LS. Leure-duPree AE. Effects of zinc deficiency on protein synthesis and expression of specific mRNAs in rat liver. 1995 Jan. Metabolism. 44(1):126-33. National Institute of Diabetes and Digestive and Kidney Diseases National Eye Institute Craven RC. Leure-duPree AE. Erdie CR. Wilson CB. Wills JW. Necessity of the spacer peptide between CA and NC in the Rous sarcoma virus gag protein. 1993 Oct. J Virol. 67(10):6246-52. National Cancer Institute Leure-duPree AE. Connor MJ. The effect of deferoxamine, an iron chelator, on the morphology of the retina. 1987. Prog Clin Biol Res. 247:517-29. National Eye Institute Leure-Dupree AE. Bridges CD. Changes in retinal morphology and vitamin A metabolism as a consequence of decreased zinc availability. 1982. Retina. 2(4):294-302. National Eye Institute